BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1078 related articles for article (PubMed ID: 28261837)

  • 21. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression.
    Jiang G; Wen L; Zheng H; Jian Z; Deng W
    Cell Biochem Funct; 2016 Oct; 34(7):505-510. PubMed ID: 27748572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. lncRNA SNHG8 Promotes the Tumorigenesis and Metastasis by Sponging miR-149-5p and Predicts Tumor Recurrence in Hepatocellular Carcinoma.
    Dong J; Teng F; Guo W; Yang J; Ding G; Fu Z
    Cell Physiol Biochem; 2018; 51(5):2262-2274. PubMed ID: 30537734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
    BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].
    Yang H; Zheng W; Zhao W; Guan C; An J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):804-11. PubMed ID: 23803188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation.
    Morita K; Shirabe K; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Ikegami T; Yamashita Y; Sugimachi K; Harimoto N; Itoh S; Ikeda T; Maehara Y
    Liver Transpl; 2016 May; 22(5):665-76. PubMed ID: 26783726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
    Lin XQ; Huang ZM; Chen X; Wu F; Wu W
    Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms.
    Dai M; Chen N; Li J; Tan L; Li X; Wen J; Lei L; Guo D
    Phytomedicine; 2021 Jul; 87():153580. PubMed ID: 34029939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-1247-5p functions as a tumor suppressor in human hepatocellular carcinoma by targeting Wnt3.
    Chu Y; Fan W; Guo W; Zhang Y; Wang L; Guo L; Duan X; Wei J; Xu G
    Oncol Rep; 2017 Jul; 38(1):343-351. PubMed ID: 28586038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
    Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J
    Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
    Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
    Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling.
    Shi DM; Li LX; Bian XY; Shi XJ; Lu LL; Zhou HX; Pan TJ; Zhou J; Fan J; Wu WZ
    J Exp Clin Cancer Res; 2018 Nov; 37(1):294. PubMed ID: 30486894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.
    Yan X; Zhu Z; Xu S; Yang LN; Liao XH; Zheng M; Yang D; Wang J; Chen D; Wang L; Liu X; Liu J; Chen RH; Zhou XZ; Lu KP; Liu H
    Sci Rep; 2017 Apr; 7():45915. PubMed ID: 28383568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p.
    Wang Y; Sun B; Sun H; Zhao X; Wang X; Zhao N; Zhang Y; Li Y; Gu Q; Liu F; Shao B; An J
    Tumour Biol; 2016 Aug; 37(8):10965-79. PubMed ID: 26891666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.
    Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD
    Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
    El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
    FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma.
    Xu X; Tao Y; Niu Y; Wang Z; Zhang C; Yu Y; Ma L
    Aging (Albany NY); 2019 Sep; 11(18):7639-7662. PubMed ID: 31527306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.